{
  "DOI": "10.1007/s10689-020-00205-1",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-020-00205-1",
  "alternative-id": [
    "205"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "24 October 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "27 August 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "12 September 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "ML reports a Consulting/Advisory Role for Agios, Celgene, and Roche/Genentech. DG has received research funding from Roche, AstraZeneca and Pfizer, educational support from Roche, Pfizer, Bayer and AstraZeneca, and has worked in an advisory capacity for Roche, Pfizer, AstraZeneca, and Merck. KC reports institutional research funding from AstraZeneca, Syndax Pharmaceuticals and has worked in an advisory capacity for Tesaro, AstraZeneca, Onc Live,  and MJH Life Sciences. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "This research was approved by the St James’s Hospital Research Ethics Committee and was performed in accordance with the Helsinki Declaration of 1975, as revised in 2000."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Power",
      "given": "Robert",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Leavy",
      "given": "Cristin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nolan",
      "given": "Carmel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "White",
      "given": "Niamh",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Clarke",
      "given": "Roisin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cadoo",
      "given": "Karen A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gallagher",
      "given": "David James",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-1354-7606",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Lowery",
      "given": "Maeve Aine",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        9,
        12
      ]
    ],
    "date-time": "2020-09-12T02:02:22Z",
    "timestamp": 1599876142000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        9,
        12
      ]
    ],
    "date-time": "2021-09-12T00:08:42Z",
    "timestamp": 1631405322000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        26
      ]
    ],
    "date-time": "2024-02-26T14:11:52Z",
    "timestamp": 1708956712150
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2020,
        9,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2021,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            9,
            12
          ]
        ],
        "date-time": "2020-09-12T00:00:00Z",
        "timestamp": 1599868800000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            9,
            12
          ]
        ],
        "date-time": "2020-09-12T00:00:00Z",
        "timestamp": 1599868800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00205-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-020-00205-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00205-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "97-101",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        9,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        9,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "NCRI",
      "key": "205_CR1",
      "unstructured": "NCRI (2019) Cancer in Ireland 1994–2017 with estimates for 2017–2019: annual report of the National Cancer Registry. NCRI, Cork",
      "volume-title": "Cancer in Ireland 1994–2017 with estimates for 2017–2019: annual report of the National Cancer Registry",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jama.2018.6228",
      "author": "C Hu",
      "doi-asserted-by": "publisher",
      "first-page": "2401",
      "issue": "23",
      "journal-title": "JAMA",
      "key": "205_CR2",
      "unstructured": "Hu C, Hart SN, Polley EC et al (2018) Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319(23):2401–2409. https://doi.org/10.1001/jama.2018.6228",
      "volume": "319",
      "year": "2018"
    },
    {
      "DOI": "10.1056/NEJMoa1903387",
      "author": "T Golan",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "4",
      "journal-title": "N Engl J Med",
      "key": "205_CR3",
      "unstructured": "Golan T, Hammel P, Reni M et al (2019) Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med 381(4):317–327. https://doi.org/10.1056/NEJMoa1903387",
      "volume": "381",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cncr.32740",
      "author": "H Maynard",
      "doi-asserted-by": "publisher",
      "first-page": "1995",
      "issue": "9",
      "journal-title": "Cancer",
      "key": "205_CR4",
      "unstructured": "Maynard H, Stadler ZK, Berger MF et al (2020) Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings. Cancer 126(9):1995–2002. https://doi.org/10.1002/cncr.32740",
      "volume": "126",
      "year": "2020"
    },
    {
      "DOI": "10.1200/JCO.18.01489",
      "author": "EM Stoffel",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "issue": "2",
      "journal-title": "J Clin Oncol",
      "key": "205_CR5",
      "unstructured": "Stoffel EM, McKernin SE, Brand R et al (2018) Evaluating susceptibility to pancreatic cancer: ASCO Provisional Clinical Opinion. J Clin Oncol 37(2):153–164. https://doi.org/10.1200/JCO.18.01489",
      "volume": "37",
      "year": "2018"
    },
    {
      "DOI": "10.1038/bjc.2013.730",
      "author": "AJ Lee",
      "doi-asserted-by": "publisher",
      "first-page": "535",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "205_CR6",
      "unstructured": "Lee AJ, Cunningham AP, Kuchenbaecker KB et al (2014) BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer 110(2):535–545. https://doi.org/10.1038/bjc.2013.730",
      "volume": "110",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10689-008-9220-x",
      "author": "DH Kim",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "205_CR7",
      "unstructured": "Kim DH, Crawford B, Ziegler J, Beattie MS (2009) Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations. Fam Cancer 8(2):153–158. https://doi.org/10.1007/s10689-008-9220-x",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cncr.26191",
      "author": "ZK Stadler",
      "doi-asserted-by": "publisher",
      "first-page": "493",
      "issue": "2",
      "journal-title": "Cancer",
      "key": "205_CR8",
      "unstructured": "Stadler ZK, Salo-Mullen E, Patil SM et al (2012) Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Cancer 118(2):493–499. https://doi.org/10.1002/cncr.26191",
      "volume": "118",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s13167-010-0037-y",
      "author": "R Janavičius",
      "doi-asserted-by": "publisher",
      "first-page": "397",
      "issue": "3",
      "journal-title": "EPMA J",
      "key": "205_CR9",
      "unstructured": "Janavičius R (2010) Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1(3):397–412. https://doi.org/10.1007/s13167-010-0037-y",
      "volume": "1",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.cancergen.2017.02.001",
      "author": "TP McVeigh",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Cancer Genet",
      "key": "205_CR10",
      "unstructured": "McVeigh TP, Cody N, Carroll C et al (2017) Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series. Cancer Genet 214:1–8. https://doi.org/10.1016/j.cancergen.2017.02.001",
      "volume": "214",
      "year": "2017"
    },
    {
      "DOI": "10.1634/theoncologist.2016-0415",
      "author": "T Golan",
      "doi-asserted-by": "publisher",
      "first-page": "804",
      "issue": "7",
      "journal-title": "Oncologist",
      "key": "205_CR11",
      "unstructured": "Golan T, Raitses-Gurevich M, Kelley RK et al (2017) Overall survival and clinical characteristics of BRCA-associated cholangiocarcinoma: a multicenter retrospective study. Oncologist 22(7):804–810. https://doi.org/10.1634/theoncologist.2016-0415",
      "volume": "22",
      "year": "2017"
    }
  ],
  "reference-count": 11,
  "references-count": 11,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-020-00205-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "20"
}